-
Spurs closing in on Man City's Marmoush after signing Savio
-
Man City sign Lille's Bouaddi for 100 mn euros
-
Celtic count the cost of Champions League flop
-
Sooriyabandara, Mendis lead Sri Lanka fightback after follow-on
-
Lebanon accuses Israel of burning forest, farmland in south
-
With ropes and chants, thousands move Japanese castle
-
Nepal floods at China border kill 8, cause 'major casualties' in Tibet
-
Zurich Diamond League: five events to watch
-
France eases cow diets as cheesemakers sweat
-
'Black smoke' chokes Pakistan maternity ward as hospital fire kills 14 infants
-
America unites in mourning for Dolly Parton
-
French flight attendant wins landmark breast cancer ruling
-
Meta and US states discuss settlement in landmark social media trial: report
-
Sri Lanka 83-2 after India enforce follow-on in second Test
-
Fire haze threatens health of millions in Indonesia, ministry warns
-
Pakistan hospital fire kills 14 infants
-
Senegal-made sickle cell treatment raises hopes, reduces costs
-
Iceland to vote on resuming EU talks in close referendum
-
Iran says Hormuz strait still closed despite transit corridor talks
-
North Korea to 'bring joy' to Kim with 100 athletes at Asian Games
-
'Our patron saint': Tennesseans mourn local hero Dolly Parton
-
US LGBTQ community mourns 'diva' Dolly Parton
-
Australian police hunt thieves in $250,000 oyster heist
-
England bid to banish booze woes as Pakistan seek self-respect
-
Coordinated attacks: Thailand's southern insurgency flares
-
High quality, low risk: record number of Japanese in Premier League
-
Asian Games chiefs hold talks as participant numbers balloon
-
Stocks edge higher as oil drops on fresh Mideast hopes
-
Too small for fries: drought shrinks Belgian potatoes
-
Pakistan's girls fight for their place in the boxing ring
-
Drought-hit Danube gives way to fossil hunt in Bulgaria
-
Five things to know about Anthropic ahead of Wall Street debut
-
Julia Curlee, CIA officer fired by White House for being transgender
-
Social media use on the rise among Australian under-16s after ban: data
-
Fave or flop? A guide to gauging video game success
-
EON Resources Inc. Announces 92 Horizontal Well Drilling Program Has Begun! $1 Million Per Month Increase Anticipated in Free Cash Flow in Q4 2026
-
Who is the Best Eyelid Surgeon in Kirkland?
-
Who Does the Best Plastic Surgery in Florida?
-
How to Manage Costs for Urgent Plumbing Repairs
-
How to Fix DIY Home Improvement Regrets Months Later
-
Eagle Plains Reports Anomalous Radioactivity from First Drillholes at the Don Lake Uranium Project, Saskatchewan
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - August 26
-
Instagram chief admits touting teen safety tool while omitting it was barely used
-
Williams-Alcaraz fall in US Open mixed quarter-finals
-
'Final Fantasy', 'The Witcher' in spotlight at Europe gaming bash
-
Mark Carney, the former central banker who said 'no' to Trump
-
Syrian Kurdish leader dissolves force that spearheaded jihadist fight
-
Segner out of South Africa tour as New Zealand injuries pile up
-
Trump raises prospect of demolishing iconic Kennedy Center
-
Meta knew teen safety tools were ineffective, witnesses testify
Todd H. Lanman to Present First Full U.S. IDE Trial Results for FDA-Approved Synergy Disc(R) at ISASS 2026
Beverly Hills spine surgeon and principal investigator will present pooled clinical outcomes following recent FDA approval of motion-preserving cervical disc technology
BEVERLY HILLS, CA / ACCESS Newswire / April 2, 2026 / Following the recent FDA Premarket Approval (PMA) of the Synergy Disc®, Todd H. Lanman, MD, a pioneer in motion-preserving spine surgery, will present the first full results from the U.S. Investigational Device Exemption (IDE) clinical trial at the International Society for the Advancement of Spine Surgery (ISASS) 2026 Annual Conference in Miami Beach, April 9-11. Dr. Lanman served as a principal investigator in the multicenter U.S. IDE study evaluating the motion-preserving cervical artificial disc, developed by Synergy Spine Solutions, for the treatment of single-level degenerative disc disease from C3-C7.

The Synergy Disc received FDA approval after demonstrating superiority to anterior cervical discectomy and fusion (ACDF) on the study's primary endpoint of composite clinical success at 24 months. In the IDE trial, the device achieved an 87.1% composite clinical success rate, significantly higher than the fusion control group.
Additional key findings included:
91.7% of patients achieved clinically meaningful improvement on the Neck Disability Index at two years compared with 75.2% in the fusion group
Lower mean neck pain scores in the Synergy Disc group (15.6 vs. 30.2 in the fusion cohort)
Lower worst arm pain scores (15.0 vs. 32.2)
Improved segmental alignment, with disc angle increasing from 2.6 degrees pre-operatively to 6.5 degrees at 24 months
Higher patient satisfaction, reported by 84.5% of Synergy Disc patients versus 61.6% of fusion patients
"Artificial disc replacement continues to evolve rapidly, and these IDE results tell a clear story - meaningful reductions in neck and arm pain, better function, and higher patient satisfaction over fusion," said Dr. Lanman. "For patients, that is just not a statistic. That is the ability to return to an active, unrestricted life. That is what motion preservation is ultimately about."
The Synergy device incorporates a lordotic polyethylene core engineered to preserve motion while improving spinal alignment, a design intended to reduce the risk of postoperative kyphosis and maintain physiologic cervical curvature.
Dr. Lanman's presentation at ISASS will provide spine surgeons with a detailed review of the IDE trial methodology, clinical outcomes, and implications for the future of cervical motion-preserving surgery.
The International Society for the Advancement of Spine Surgery (ISASS) Annual Conference is one of the premier scientific meetings dedicated to spine innovation and motion-preservation technologies. The 2026 meeting will bring together leading spine surgeons, researchers, and industry innovators to discuss emerging technologies and advances in spinal care.
About Dr. Todd H. Lanman
Todd Lanman, MD has over three decades of experience as a spinal neurosurgeon and has spent the last 25 years practicing spine surgery in Beverly Hills. In addition to being a world-renowned spinal surgeon, Dr. Lanman has also had 11 spinal surgeries including spinal fusions and artificial disc replacements. Because of these experiences as surgeon and as patient, Dr. Lanman brings a unique perspective to his surgical practice.
About Lanman Spinal Neurosurgery
Lanman Spinal Neurosurgery is committed to improving patients' quality of life by relieving pain and restoring spinal motion. The Beverly Hills practice has been at the leading edge of spine health for the past quarter of a century. Lanman Spinal Neurosurgery has and continues to pioneer artificial disc replacement and fusion revision surgeries to help neck and back pain sufferers live their best lives.
About Synergy Spine Solutions
Synergy Spine Solutions is a medical device company focused on improving the quality of life for patients undergoing spine surgery. The company develops motion-preserving technologies designed to treat degenerative disc disease while supporting the spine's natural curvature. Its flagship product, the FDA-approved Synergy Disc®, features a built-in 6-degree lordotic core designed to not only preserve motion but also improve sagittal alignment.
Media Contact:
Brandi Kamenar
Brandi Kamenar Brand Management
BrandiKamenar.com
Email: [email protected]
Phone: (310) 734-6180
SOURCE: Lanman Spinal Neurosurgery
View the original press release on ACCESS Newswire
D.Johnson--AT